High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$3.7M
$3,697,196
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
KNSA
M
Kiniksa Pharmaceuticals International, plc
Tessari Eben
• COO
Equity Compensation
2025-12-15
$52,980x2
|
||||||
| KNSA |
Kiniksa Pharmaceuticals International, plc
|
COO
Equity Compensation
|
2025-12-15 | $52,980x2 | M | Form 4 |
|
KNSA
S
Kiniksa Pharmaceuticals International, plc
Tessari Eben
• COO
10b5-1 SellΔOwn -42.0%
2025-12-15
$500,715
|
||||||
| KNSA |
Kiniksa Pharmaceuticals International, plc
|
COO
10b5-1 SellΔOwn -42.0%
|
2025-12-15 | $500,715 | S | Form 4 |
|
KNSA
M
Kiniksa Pharmaceuticals International, plc
Tessari Eben
• COO
Equity Compensation
2025-11-26
$4,578x2
|
||||||
| KNSA |
Kiniksa Pharmaceuticals International, plc
|
COO
Equity Compensation
|
2025-11-26 | $4,578x2 | M | Form 4 |
| KNSA |
Kiniksa Pharmaceuticals International, plc
|
COO
10b5-1 Sell
|
2025-11-26 | $8,578 | S | Form 4 |
| KNSA |
Kiniksa Pharmaceuticals International, plc
|
COO
Other
|
2025-11-17 | $57,395 | M | Form 4 |
|
KNSA
S
Kiniksa Pharmaceuticals International, plc
Tessari Eben
• COO
10b5-1 Sell
2025-11-17
$514,224x2
|
||||||
| KNSA |
Kiniksa Pharmaceuticals International, plc
|
COO
10b5-1 Sell
|
2025-11-17 | $514,224x2 | S | Form 4 |
| KNSA |
Kiniksa Pharmaceuticals International, plc
|
COO
Other
|
2025-10-14 | $57,395 | M | Form 4 |
|
KNSA
S
Kiniksa Pharmaceuticals International, plc
Tessari Eben
• COO
10b5-1 Sell
2025-10-14
$465,843x2
|
||||||
| KNSA |
Kiniksa Pharmaceuticals International, plc
|
COO
10b5-1 Sell
|
2025-10-14 | $465,843x2 | S | Form 4 |
| KNSA |
Kiniksa Pharmaceuticals International, plc
|
COO
Other
|
2025-09-29 | $752,640 | M | Form 4 |
|
KNSA
S
Kiniksa Pharmaceuticals International, plc
Tessari Eben
• COO
10b5-1 SellΔOwn -54.9%
2025-09-29
$1,609,860Large
|
||||||
| KNSA |
Kiniksa Pharmaceuticals International, plc
|
COO
10b5-1 SellΔOwn -54.9%
|
2025-09-29 | $1,609,860Large | S | Form 4 |
| KNSA |
Kiniksa Pharmaceuticals International, plc
|
COO
Other
|
2025-09-15 | $57,395 | M | Form 4 |
|
KNSA
S
Kiniksa Pharmaceuticals International, plc
Tessari Eben
• COO
10b5-1 Sell
2025-09-15
$597,976x2
|
||||||
| KNSA |
Kiniksa Pharmaceuticals International, plc
|
COO
10b5-1 Sell
|
2025-09-15 | $597,976x2 | S | Form 4 |